The Drug Enforcement Administration last week published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.

Effective Oct. 30, the rule allows certain practitioners to treat more patients; permanently adds nurse practitioners and physician assistants to the definition of “qualifying other practitioner”; and permits practitioners to complete required opioid training in medical school or residency as well as post-residency.

DEA will accept comments on the rule through Jan. 4.

DEA also will accept comments through Jan. 4 on a proposed rule implementing requirements to report suspicious orders of controlled substances under the Preventing Drug Diversion Act of 2018. The rule would offer multiple options for reporting suspicious orders; establish a centralized database for reporting; define key terms; and require specific record-keeping practices.

Related News Articles

Headline
Congress should urge the Department of Health and Human Services’ Office for Civil Rights to immediately withdraw its new rule regarding so-called “online…
Headline
The director and nurse manager for pediatric emergency mental health services at UMass Memorial Health in Massachusetts share how the health system is helping…
Headline
The Senate Sept. 26 voted 77-19 to begin debate on a continuing resolution that would continue funding for government programs through Nov. 17. The Senate…
Perspective
As we’ve seen from recent media reports, Congress — and especially the House right now — continues to struggle to put together a plan to keep the government…
Headline
AHA Sept. 20 urged leaders of the Senate Health, Education, Labor and Pensions Committee to remove from the Bipartisan Primary Care and Health Workforce…
Headline
AHA’s chief nursing officer and chief physician executive encourage hospitals and health systems to ensure the questions asked on licensing, credentialing and…